A Clinical Study to Evaluate Enlicitide (MK-0616) Formulations in Healthy Adult Participants (MK-0616-035)
Clinical trial NCT06880874 · COMPLETED
Trial details
- NCT number
- NCT06880874
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-02
- Primary completion
- 2025-05-16
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.